19 completed, 7 unknown, 2 not yet recruiting, 2 recruiting. 34 Phase 2, 7 Phase 1, 7 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 34 | Completed 19, Unknown 7, Not yet recruiting 2, Recruiting 2, Terminated 2, Withdrawn 2 |
| Phase 1 | 7 | Completed 3, Unknown 2, Terminated 1, Withdrawn 1 |
| Phase 3 | 7 | Completed 7 |
Follow Postpartum Hemorrhage: new trials by email Literature Review of Postpartum Hemorrhage trials Research Report on Postpartum Hemorrhage
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sublingual Oxytocin for the Prevention of Post-partum Hemorrhage Oxytocin sublingual, Oxytocin IM - Post Partum Hemorrhage | Phase 2 | Not yet recruiting | Insud Pharma | 330 | 2026-05-30 | 2026-04-23 |
| Role of Intravenous Calcium to Decrease Blood Loss During Intrapartum Cesarean Section Calcium Chloride, Placebo - Post Partum Haemorrhage, Cesarean Section Surgery | Phase 2 | Not yet recruiting | Pak Emirates Military Hospital | 182 | 2026-05-01 | 2026-04-24 |
| Oxytocin Pharmacokinetics and Pharmacodynamics deuterated oxytocin (d5OT) - Post Partum Hemorrhage, Cesarean Section Complications | Phase 2 | Recruiting | Stanford University | 100 | 2025-01-01 | 2026-08-21 |
| High Or Low Dose pOstpartUm Oxytocin at the Time of Cesarean Birth Oxytocin - Postpartum Hemorrhage, Pregnancy Complications | Phase 2 | Withdrawn | University of Chicago | 2024-10-01 | 2024-12-10 | |
| Efficacy of Carbetocin in Prevention of Postpartum Hemorrhage in Obese Versus Non Obese Women Carbetocin 100 Microgram/mL Solution for Injection - Obesity, Maternal, Post Partum Hemorrhage | Phase 1 / Phase 2 | Completed | Cairo University | 150 | 2023-07-06 | 2024-01-22 |
| Prevention of Postpartum Hemorrhage With Tranexamic Acid Tranexamic acid, No intervention - Post Partum Hemorrhage | Phase 2 | Recruiting | Inova Health Care Services | 120 | 2022-12-28 | 2026-10-16 |
| Prevention of Primary Postpartum Haemorrhage Misoprostol, Oxytocin - Primary, Post Partum Hemorrhage | Phase 2 | Unknown | Islamabad Medical and Dental College | 180 | 2021-02-03 | 2021-02-25 |
| A Program to Evaluate Riastap® and FIBTEM® for the Early Control and Treatment of Postpartum Hemorrhage (PERFECT PPH) fibrinogen concentrate, Placebo - Postpartum Hemorrhage | Phase 1 / Phase 2 | Withdrawn | Yale University | 2021-01-01 | 2021-03-15 | |
| Tranexamic Acid Versus Sublingual Misoprostol in Reducing Blood Loss During Elective CS in High Risk Cases Misoprostol, Tranexamic acid, Oxytocin - Post Partum Hemorrhage | Phase 2 | Completed | Cairo University | 345 | 2020-01-20 | 2025-07-28 |
| Tranexamic Acid for the Prevention of Postpartum Haemorrhage Tranexamic Acid 100 milligram/Milliliter, Oxytocin - Postpartum Hemorrhage | Phase 1 / Phase 2 | Unknown | Benha University | 60 | 2020-01-01 | 2021-01-13 |
| Tranexamic Acid for Prevention of Hemorrhage in Cesarean Delivery Tranexamic Acid, Placebo - Post Partum Hemorrhage, Fibrinolysis; Hemorrhage | Phase 2 / Phase 3 | Completed | University of Texas Southwestern Medical Center | 110 | 2019-06-17 | 2021-01-19 |
| Intrauterine Misoprostol Versus Rectal Misoprostol in Reducing Blood Loss During Cesarean Section Misoprostol - Hemorrhage, Postpartum | Phase 2 | Unknown | Cairo University | 98 | 2018-11-15 | 2020-03-18 |
| Use of TXA to Prevent Postpartum Hemorrhage TXA (1g), Placebo (0.9% saline) - Post Partum Hemorrhage | Phase 2 | Unknown | Sunnybrook Health Sciences Centre | 31 | 2018-03-06 | 2022-09-13 |
| Prevention of Postpartum Hemorrhage With Tranexamic Acid Tranexamic Acid - Postpartum Hemorrhage | Phase 2 | Completed | George Washington University | 43 | 2018-01-02 | 2025-03-25 |
| Tranexamic Acid in Preventing Postpartum Hemorrhage in High Risk Pregnancies During Elective Cesarean Section Tranexamic Acid - Postpartum Hemorrhage | Phase 2 / Phase 3 | Completed | Mansoura University | 140 | 2016-08-01 | 2017-11-27 |
| Prophylactic Oxytocin Before Versus After Placental Delivery to Reduce Blood Loss in Vaginal Delivery oxytocin - Postpartum Hemorrhage | Phase 2 | Unknown | Ain Shams Maternity Hospital | 400 | 2016-08-01 | 2017-03-15 |
| Sublingual Misoprostol to Reduce Blood Loss During Elective Cesarean Delivery Misoprostol Oral Tablet, Ranitidine Oral Tablet - Hemorrhage Postpartum | Phase 2 | Unknown | Ain Shams Maternity Hospital | 158 | 2016-07-01 | 2017-05-04 |
| Misoprostol+Oxytocin vs. Carbetocin in CS Misoprostol, Oxytocin, Carbetocin - Cesarean Section | Phase 2 / Phase 3 | Completed | Ain Shams University | 600 | 2016-05-01 | 2020-07-08 |
| Two Different Regimens of Misoprostol in Retained Placenta Misoprostol - Postpartum Haemorrhage, Retained Placenta | Phase 2 | Completed | Hawler Medical University | 509 | 2016-03-01 | 2019-02-22 |
| Tranexamic Acid and Ethamsylate For Preventing PPH in Patient Undergoing LSCS at High Risk For PPH Tranexamic Acid and Ethamsylate - Postpartum Hemorrhage | Phase 1 / Phase 2 | Unknown | Ahmed Alanwar | 64 | 2015-11-01 | 2015-11-30 |
Showing 20 of 34. Sign in to see all of them.
Hemorrhage (5) · Thrombosis (2) · Anemia (1) · Anemia, Neonatal (1) · Jaundice (1) · Jaundice, Neonatal (1) · Pain (1) · Placenta Accreta (1) · Placenta Previa (1) · Placenta, Retained (1) · Pregnancy Complications (1) · Pregnancy in Obesity (1)
Female Urogenital Diseases and Pregnancy Complications (34) · Obstetric Labor Complications (34) · Pathologic Processes (34) · Pathological Conditions, Signs and Symptoms (34) · Puerperal Disorders (34) · Urogenital Diseases (34) · Uterine Hemorrhage (34) · Pregnancy Complications (33) · Hemorrhage (29) · Placenta Diseases (3) · Signs and Symptoms (3) · Cardiovascular Diseases (2) · Embolism and Thrombosis (2) · Vascular Diseases (2) · Body Weight (1)
Misoprostol (11) · Oxytocin (9) · Tranexamic Acid (8) · Sodium Chloride (3) · Fibrinogen (2) · Saline Solution (2) · carbetocin (2) · Arthotec (1) · Calcium Chloride (1) · Control Groups (1) · Ethamsylate (1) · Ferritins (1) · Glucose (1) · Hysterectomy (1) · Injections (1)
Ain Shams University (3) · Cairo University (3) · Ain Shams Maternity Hospital (2) · Assiut University (2) · Benha University (2) · Qazvin University Of Medical Sciences (2) · Aga Khan University (1) · Ahmed Alanwar (1) · Brigham and Women's Hospital (1) · Copenhagen University Hospital at Herlev (1) · George Washington University (1) · Hawler Medical University (1) · Inova Health Care Services (1) · Insud Pharma (1) · International Centre for Diarrhoeal Disease Research, Bangladesh (1)
Egypt (11) · United States (5) · Iran (4) · Pakistan (3) · Bangladesh (1) · Canada (1) · Denmark (1) · Iraq (1) · Nigeria (1) · Switzerland (1)
Abubaker M Elnashar, MD (1) · Amgad E. Abou-Gamrah, Ass.Prof. (1) · Aminur Rahman, MBBS,MSc (1) · Amr Yehia, MD, MRCOG (1) · Anna Palatnik, MD (1) · Anne J. Wikkelsoe, MD (1) · Arash Afshari, MD (1) · Ariana Kh. Jawad, Assistant professor (1) · Ashish Premkumar, MD, PhD (1) · Asim Q Alam, MD, FRCPC (1) · Bahar Q. Muhammad, CABOG (1) · Dr Huma Shaireen, MBBS, FCPS (1) · Dr Zulfiqar Bhutta, MBBS, PhD (1)
PMID 10467792, PMID 10908457, PMID 11502292, PMID 14600674, PMID 15954876, PMID 16581405, PMID 16842791, PMID 17197859, PMID 17634155, PMID 19432563, PMID 19943825, PMID 20009308, PMID 22540529, PMID 22805300, PMID 22882240, PMID 25586727, PMID 28707488, PMID 29025850, PMID 31598047, PMID 32609374, PMID 33064852, PMID 33248975, PMID 33705565, PMID 35038612, PMID 36934142, PMID 37626292
2009 (1), K23HL141640 (1), KL2TR001877 (1), R01HD110109 (1), UL1TR001876 (1)